BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36239661)

  • 1. Semaphorin 4A as a Potential Biomarker for Diagnosis of Systemic Lupus Erythematosus.
    He R; Tan X; Xiang J; Zhu J; Jiang Y; Liu W; Li Y; Guo B; Xing Y
    Immunol Invest; 2023 Jan; 52(1):104-116. PubMed ID: 36239661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell specific upregulation of Sema4A as risk factor for autoimmunity in systemic lupus erythematosus and rheumatoid arthritis.
    Cavalcanti CAJ; Germoglio V; de Azevêdo Silva J; Glesse N; Vianna P; Cechim G; Monticielo OA; Xavier RM; Brenol JCT; Brenol CV; Fragoso TS; Barbosa AD; Duarte ÂLBP; Oliveira RDR; Louzada-Júnior P; Donadi EA; Chies JAB; Crovella S; Sandrin-Garcia P
    Autoimmunity; 2020 Mar; 53(2):65-70. PubMed ID: 31876207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus].
    Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195
    [No Abstract]   [Full Text] [Related]  

  • 4. Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity.
    Gravand A; Alesaeidi S; Khoshbakht S; Saghaei M; Kenarangi T; Mosallaei M; Soosanabadi M
    Clin Rheumatol; 2023 Dec; 42(12):3387-3395. PubMed ID: 37597101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.
    Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF
    Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNAs hsa_circ_0000479 in peripheral blood mononuclear cells as novel biomarkers for systemic lupus erythematosus.
    Luo Q; Zhang L; Fang L; Fu B; Guo Y; Huang Z; Li J
    Autoimmunity; 2020 May; 53(3):167-176. PubMed ID: 32093518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
    Luo Q; Zhang L; Xiong L; Fu B; Guo Y; Huang Z; Li J
    Clin Exp Rheumatol; 2020; 38(5):822-833. PubMed ID: 32940208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis.
    Wang L; Song G; Zheng Y; Tan W; Pan J; Zhao Y; Chang X
    Arthritis Res Ther; 2015 Aug; 17(1):227. PubMed ID: 26303122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis.
    Avouac J; Pezet S; Vandebeuque E; Orvain C; Gonzalez V; Marin G; Mouterde G; Daïen C; Allanore Y
    Arthritis Rheumatol; 2021 Sep; 73(9):1579-1588. PubMed ID: 33605067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
    Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y
    Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.
    Yolbas S; Kara M; Kalayci M; Yildirim A; Gundogdu B; Aydin S; Koca SS
    Adv Clin Exp Med; 2018 Dec; 27(12):1637-1641. PubMed ID: 30141839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
    Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V
    Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of anti-collectin 11 in systemic lupus erythematosus].
    Deng XL; Zhong LJ; Sun L; Li CH; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):982-986. PubMed ID: 27987501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phosphatidylserine-specific phospholipase A
    Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
    Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
    Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.